The association of choroidal thickness with rheumatoid factor and anti-cyclic citrullinated peptide in rheumatoid arthritis

被引：0
|
作者：
Arif Ülkü Yener
Kubilay Şahin
机构：
[1] Keçiören Training and Research Hospital,Department of Ophthalmology
[2] Keçiören Training and Research Hospital,Department of Rheumatology
来源：
International Ophthalmology | 2020年 / 40卷
关键词：
Rheumatoid arthritis; Choroidal thickness; Optical coherence tomography angiography; Rheumatoid factor; Anti-cyclic citrullinated peptide antibody;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：935 / 941
页数：6
相关论文
共 50 条
  • [31] Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and comorbidity
    Stamenkovic, Doris
    Stiglic-Rogoznica, Nives
    Stiglic, Mirna
    Avancini-Dobrovic, Viviana
    Grubisic-Karavanic, Vlasta
    Frlan-Vrgoe, Ljubinka
    Radovic, Endi
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (05) : 706 - 707
  • [32] Anti-cyclic citrullinated peptide antibodies in elderly onset rheumatoid arthritis
    Riccieri, V.
    Macri, V.
    Germano, V.
    Vasile, M.
    Sciarra, I.
    Scrivo, R.
    Spadaro, A.
    Valesini, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 300 - 300
  • [33] Biological significance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis
    Arkfeld, Daniel G.
    ANNALS OF INTERNAL MEDICINE, 2008, 148 (05) : 403 - 403
  • [34] Diagnostic performances of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis
    Sghiri, Rim
    Bouagina, Elyes
    Zaglaoui, Hela
    Mestiri, Hajer
    Harzallah, Latifa
    Harrabi, Imed
    Ghannouchi, Mehdi
    Mokhtar, Faycel
    Ghedira, Ibtissem
    RHEUMATOLOGY INTERNATIONAL, 2007, 27 (12) : 1125 - 1130
  • [35] Diagnostic performances of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis
    Rim Sghiri
    Elyes Bouagina
    Hela Zaglaoui
    Hajer Mestiri
    Latifa Harzallah
    Imed Harrabi
    Mehdi Ghannouchi
    Faycel Mokhtar
    Ibtissem Ghedira
    Rheumatology International, 2007, 27 : 1125 - 1130
  • [36] Salivary anti-cyclic citrullinated peptide as a screening tool for rheumatoid arthritis
    Mortazavi, Nazanin
    Abdolahi, Nafiseh
    Saeidi, Mohsen
    Vakili, Mohammad Ali
    Mohebrad, Pouria
    ARCHIVES OF RHEUMATOLOGY, 2023, 38 (01) : 95 - 100
  • [37] Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis
    Liao, K. P.
    Batra, K. L.
    Chibnik, L.
    Schur, P. H.
    Costenbader, K. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (11) : 1557 - 1561
  • [38] Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients
    Sulaiman, Farah Nadiah
    Wong, Kah Keng
    Ahmad, Wan Aireene Wan
    Ghazali, Wan Syamimee Wan
    MEDICINE, 2019, 98 (12)
  • [39] Diagnostic value of third generation anti-cyclic citrullinated peptide assay in rheumatoid factor negative rheumatoid arthritis
    Song, Jiying
    Li, Mingxin
    Li, Shuang
    Ma, Jia
    Liu, Danqiu
    Zhao, Qin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (10): : 10728 - 10733
  • [40] Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis
    Ueda-Hayakawa, Ikuko
    Hasegawa, Minoru
    Kumada, Sayako
    Tanaka, Chihiro
    Komura, Kazuhiro
    Hamaguchi, Yasuhito
    Takehara, Kazuhiko
    Fujimoto, Manabu
    RHEUMATOLOGY, 2010, 49 (11) : 2135 - 2139
12345